Atlas Trials

Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma

Clinical trial NCT00882063 · COMPLETED

Trial details

NCT number
NCT00882063
Sponsor
Piramal Enterprises Limited
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed and/or Refractory Multiple Myeloma
Start date
2008-01-01
Primary completion
2009-11-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.